MAEA and ovarian carcinoma: Previous studies have demonstrated the inhibitory effects of anti-EMP 2 recombinant bivalent antibody fragments (diabodies) on the proliferation and induction of apoptosis in uterine endometrial and ovarian cancer [39,98].